John A Colliopoulos

Title: John A Colliopoulos: Innovator in Microcrystalline Cellulose Technologies

Introduction

John A Colliopoulos is a notable inventor based in Princeton Junction, NJ (US). He has made significant contributions to the field of microcrystalline cellulose, holding 2 patents that showcase his innovative approach to creating stable pharmaceutical suspensions.

Latest Patents

His latest patents include "Ultra-fine microcrystalline cellulose compositions and process" and "MCC: alginate pharmaceutical suspensions." The first patent discloses ultra-fine microcrystalline cellulose compositions that produce highly stable suspensions and dispersions, where the particle size does not exceed about 0.7 µm. This composition includes an attriting aid that not only reduces the size of the cellulose microcrystals but also adds desired properties to the dispersions. The second patent describes novel pharmaceutical suspensions that comprise a pharmaceutically active ingredient suspended in aqueous media, utilizing attrited microcrystalline cellulose coprocessed with a calcium sodium alginate salt complex barrier dispersant.

Career Highlights

John A Colliopoulos is currently associated with Fmc Corporation, where he continues to develop innovative solutions in his field. His work has significantly impacted the pharmaceutical industry, particularly in the formulation of stable and effective drug suspensions.

Collaborations

He collaborates with talented professionals such as Sheila M Dell and Aaron Chip Venables, contributing to a dynamic and innovative work environment.

Conclusion

John A Colliopoulos exemplifies the spirit of innovation in the field of microcrystalline cellulose technologies. His patents reflect a commitment to advancing pharmaceutical formulations, making a lasting impact on the industry.